Author

K. Howard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Arazi· 1 shared A. Bhardwaj· 1 shared A. Denny· 1 shared A. Fava· 1 shared A. G. Bruce· 1 shared A. Griffith· 1 shared A. Horisberger· 1 shared A. Hundt· 1 shared

Activity by Year

2018-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Arazi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis

A. Horisberger, A. Griffith, J. Keegan, A. Arazi, J. Pulford, E. Murzin, K. Howard, B. Hancock, A. Fava, T. Sasaki, T. Ghosh, J. Inamo, R. Beuschel, Y. Cao, K. Preisinger, , Accelerating Medicines Pa

The paper identifies three immunologically distinct groups in lupus nephritis patients based on blood immunophenotyping, correlating with histopathology, treatment response, and renal outcomes.

bioRxiv · Jan 14, 2024Immunology

Regulated Induced Proximity Targeting Chimeras (RIPTACs): a Novel Heterobifunctional Small Molecule Therapeutic Strategy for Killing Cancer Cells Selectively

K. Raina, C. D. Forbes, R. Stronk, J. P. Rappi, K. J. Eastman, S. W. Gerritz, X. Yu, H. Li, A. Bhardwaj, M. Forgione, A. Hundt, M. P. King, Z. M. Posner, A. Denny, A. McGovern, , C. M. Crews

This paper introduces RIPTACs, a new class of heterobifunctional small molecules that selectively kill cancer cells by inducing protein-protein interactions that disrupt essential cellular functions.

bioRxiv · Jan 1, 2023 · PreprintCancer Biology

Experimental co-transmission of simian immunodeficiency virus (SIV) and the macaque homologs of the Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV)

A. G. Bruce, S. Barcy, J. Staheli, H. Bielefeldt-Ohmann, M. Ikoma, K. Howard, T. M. Rose

This study successfully transmits RFHV and LCV from saliva in macaques, showing differential lytic activation and immune control of the viruses.

bioRxiv · Oct 1, 2018Microbiology